Category
6 articles
A Johns Hopkins vaccine targeting KRAS mutations safely triggered immune responses in 90% of participants, a breakthrough in pancreatic cancer prevention.
Blood tests for the Alzheimer biomarker p-tau217 can predict cognitive impairment risk up to 10 years before symptoms appear, new study finds.
Stockholm3 blood test detects 90% of aggressive prostate cancers vs. 74% for PSA, study finds. The breakthrough could transform prostate cancer screening.
Moderna and Merck's mRNA vaccine reduced melanoma recurrence risk by 49% over five years, offering new hope for advanced skin cancer patients.
A personalized mRNA cancer vaccine combined with Keytruda reduced melanoma recurrence risk by 49% over five years, according to new clinical trial data.
New oral drug daraxonrasib nearly doubled survival in metastatic pancreatic cancer patients, marking a breakthrough against one of the deadliest cancers.